Sun Pharma looks for 25 percent growth in consumer health business


Sun Pharma, India’s largest drug producer and the fifth largest generics maker in the world, is looking to boost its consumer healthcare business. Sun Pharma expects to grow its consumer healthcare business by as much as 25 percent in 2016. Sun Pharma believes there is still significant growth to be found in expanding its global consumer healthcare portfolio.

Read the source article in Reuters

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>